BioSpace News Archive

MEI Pharma, Inc. issued the following letter to shareholders reiterating the Board of Directors recommendation to vote FOR the pending transaction with Infinity Pharmaceuticals, Inc. in connection with the Company’s special meeting on July 14, 2023.

Sangamo Therapeutics, Inc. and Voyager Therapeutics, Inc. (Nasdaq: VYGR), today announced the parties have entered into a definitive license agreement for a potential treatment of prion disease.

Exscientia plc (Nasdaq: EXAI) announced today that it is expanding its technology management structure to accelerate application of Exscientia’s innovative technologies to catalyse instrumental change in the way drug candidates are being discovered, designed and developed for patients in need of innovative therapies.

Elucent Medical today announced that it has appointed Jason Pesterfield as its new President and Chief Executive Officer and Kirk G. Jacquay as the company’s new Chief Finance Officer.

IQVIA™, a global provider of data, analytics, technology solutions and services to the life sciences industry, was recognized as the highest scoring provider in the ‘Leader’ category of Everest Group’s Life Sciences Sales and Marketing Operations PEAK Assessment.

As the field of neurosurgery nears its centennial, it is spurred on by the introduction of digitized medical imaging, hybrid operating rooms, and advanced brain research.

Organicell Regenerative Medicine, Inc . is pleased to announce the appointment of Howard L. Golub, MD, PhD as its new Executive Vice President (EVP) and Chief Science Officer (CSO).

Alentis Therapeutics announced today the appointment of Dr. Luca Santarelli as the Chair of its Board of Directors.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, effective July 10, 2023.

The board of directors of The University of Tennessee Medical Center has selected Dr. Keith Gray as president and chief executive officer, effective April 1, 2024.